Solid tumors except for head and neck and hematologic cancers solid tumour, oralmucositis
Conditions
Interventions
Sponsors
Soutome Sakiko
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients undergoing chemotherapy for solid tumors except head and neck and hematologic cancers at participating centers. Any type or combination of anticancer drugs, molecular targeted drugs, and immune checkpoint inhibitors. (2) Patients who are 18 years or older at the time of consent are obtained. (3) Patients who can personally provide written consent of their own free will after receiving a thorough explanation of the study and fully understanding their participation in the study
Exclusion criteria
Exclusion criteria: 1) Patients with a history of hypersensitivity to betamethasone sodium phosphate 2) Patients who cannot be gargle 3) Patients who have already developed oral mucositis 4) Patients with oral candidiasis 5) Patients deemed inappropriate for inclusion in the study by the principal investigator or sub investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence and timing of onset of Grade 1 oral mucositis | — |
Secondary
| Measure | Time frame |
|---|---|
| Presence and timing of onset of Grade 2 and 3 oral mucositis Onset and timing of oral candidiasis Completion of chemotherapy or not | — |
Contacts
Public ContactSakiko Soutome
Nagasaki University Hospital
Outcome results
None listed